Słowniczek Badanie
RIDD trial
Polski: (tłumaczenie w przygotowaniu)
Repurposing anti-TNF for Dupuytren Disease — a phase 2b randomised, double-blind, placebo-controlled trial of intranodular adalimumab in early-stage disease, published by Nanchahal and colleagues in Lancet Rheumatology 2022. Demonstrated softening and reduction in nodule size at 12 months; phase 3 progression pending as of 2026.